• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Celanese Corporation filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

    5/15/25 9:00:48 PM ET
    $CE
    Major Chemicals
    Industrials
    Get the next $CE alert in real time by email
    false --12-31 0001306830 0001306830 2025-05-14 2025-05-14 0001306830 us-gaap:CommonStockMember 2025-05-14 2025-05-14 0001306830 CE:SeniorUnsecuredNotesDue2026Member 2025-05-14 2025-05-14 0001306830 CE:SeniorUnsecuredNotesDue2027Member 2025-05-14 2025-05-14 0001306830 CE:SeniorUnsecuredNotesDue2028Member 2025-05-14 2025-05-14 0001306830 CE:SeniorUnsecuredNotesDue2029Member 2025-05-14 2025-05-14 0001306830 CE:SeniorUnsecuredNotesDue2031Member 2025-05-14 2025-05-14 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT 

    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported): May 15, 2025 (May 14, 2025)

     

    CELANESE CORPORATION

     (Exact name of registrant as specified in its charter)

     

    Delaware   001-32410   98-0420726

    (State or other jurisdiction
    of incorporation)

     

    (Commission File
    Number)

     

    (IRS Employer
    Identification No.)

     

    222 West Las Colinas Blvd. Suite 900N, Irving, TX 75039

    (Address of Principal Executive Offices) (Zip Code)

     

    Registrant's telephone number, including area code: (972) 443-4000

     

    N/A

    (Former name or former address, if changed since last report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

     

    ¨  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ¨  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ¨      Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ¨  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

      

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of Each Class   Trading Symbol(s)    Name of Each Exchange on Which Registered
    Common Stock, par value $0.0001 per share   CE   New York Stock Exchange
    4.777% Senior Notes due 2026   CE /26A   New York Stock Exchange
    2.125% Senior Notes due 2027   CE /27   New York Stock Exchange
    0.625% Senior Notes due 2028   CE /28   New York Stock Exchange
    5.337% Senior Notes due 2029   CE /29A   New York Stock Exchange
    5.000% Senior Notes due 2031   CE /31   New York Stock Exchange

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company   ¨

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ¨

     

     

     

     

     

    Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

     

    As discussed under Item 5.07 of this Current Report on Form 8-K, on May 14, 2025, Celanese Corporation (the “Company”) held its 2025 Annual Meeting of Shareholders (the “2025 Annual Meeting”) and the Company’s shareholders approved amendments to the Company’s Second Amended and Restated Certificate of Incorporation (the “Charter”) to remove the supermajority voting requirements in the Charter and replace them with majority voting standards, and to adopt certain other “housekeeping” amendments to the Charter (collectively, the “Charter Amendments”). The Charter Amendments are more fully described in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on March 24, 2025, in connection with the 2025 Annual Meeting (the “Proxy Statement”). In connection with implementing the Charter Amendments, on May 15, 2025, the Company filed with the Secretary of State of the State of Delaware a Certificate of Amendment setting forth the Charter Amendments, a Certificate of Elimination eliminating all provisions relating to a previously redeemed class of Company preferred stock of which no shares were outstanding, and a Restated Certificate of Incorporation (the “Restated Certificate”) that restated and integrated the Charter (as amended through the filing of the Certificate of Amendment and the Certificate of Elimination referenced above). The Company’s Board of Directors (the “Board”) had previously approved the filing of each of these documents, and each was effective upon filing on May 15, 2025.

     

    In connection with approving the Charter Amendments and recommending them to the Company’s shareholders for approval, and as disclosed in the Proxy Statement, the Board also approved conforming amendments to the Company’s Seventh Amended and Restated By-laws, as amended (the “By-laws Amendments”). The Board approved the By-laws Amendments contingent upon shareholder approval and implementation of the related Charter Amendments. Accordingly, the By-laws Amendments became effective upon the filing of the Certificate of Amendment with the Secretary of State of the State of Delaware on May 15, 2025.

     

    The foregoing description of the Charter Amendments, the Certificate of Elimination, the Restated Certificate and the By-laws Amendments is not complete and is qualified in its entirety by reference to the Certificate of Amendment, the Certificate of Elimination, the Restated Certificate, and the Amended and Restated By-laws, each dated May 15, 2025, which are filed as Exhibits 3.1, 3.2, 3.3 and 3.4 hereto, respectively.

     

    Item 5.07 Submission of Matters to a Vote of Security Holders.

     

    During the 2025 Annual Meeting, the Company’s shareholders were asked to consider and vote upon the following proposals: (1) election of thirteen directors to the Board to serve for a term that expires at the annual meeting of shareholders in 2026 and until their successors are duly elected and qualified or their earlier resignation or retirement; (2) ratification of the selection of KPMG LLP as the Company’s independent registered public accounting firm for 2025; (3) an advisory vote to approve executive compensation; (4) approval of four Charter Amendments to: (4a) provide that the By-laws may be amended by majority vote; (4b) allow the Charter to be amended in the future by majority vote; (4c) allow the filling of open Board seats at statutorily required special meetings under the standard in the By-laws; and (4d) allow directors to be removed by majority vote; and (5) an advisory vote on a shareholder proposal requesting simple majority vote Charter and By-laws amendments.

     

    As of the 2025 Annual Meeting record date of March 17, 2025, there were 111,754,189 shares of the Company’s Common Stock issued and outstanding and entitled to be voted at the 2025 Annual Meeting, if represented in person or by proxy at the 2025 Annual Meeting. A total of 100,831,777 shares were voted in person or by proxy (90.22% quorum). For each proposal, the shareholder voting results were as follows:

     

    1.Election of Directors. Each of the director nominees was elected to serve for a term which expires at the annual meeting of shareholders in 2026 by the votes set forth in the table below.

     

    Nominee   Voted For   Voted Against   Abstain   Broker Non-Votes
    Bruce E. Chinn   95,808,405   340,702   62,886   4,619,784
    Edward G. Galante   93,716,220   2,471,334   24,439   4,619,784
    Timothy Go   95,786,375   360,274   65,344   4,619,784
    Kathryn M. Hill   95,585,901   564,375   61,717   4,619,784
    David F. Hoffmeister   91,424,192   4,742,876   44,925   4,619,784
    Dr. Jay V. Ihlenfeld   93,867,328   2,300,812   43,853   4,619,784
    Deborah J. Kissire   92,610,858   3,492,517   108,618   4,619,784
    Michael Koenig   95,628,123   522,114   61,756   4,619,784
    Christopher J. Kuehn   95,810,658   336,777   64,558   4,619,784
    Ganesh Moorthy   93,706,890   2,396,461   108,642   4,619,784
    Scott A. Richardson   95,844,035   344,874   23,084   4,619,784
    Kim K.W. Rucker   89,621,891   6,504,450   85,652   4,619,784
    Scott M. Sutton   95,840,791   335,158   36,044   4,619,784

     

    2

     

     

    2.Ratification of the Selection of Independent Registered Public Accounting Firm. The selection of KPMG LLP as the Company’s independent registered public accounting firm for 2025 was ratified by the shareholders by the votes set forth in the table below.

     

    Voted For   Voted Against   Abstain
    98,120,949   2,691,048   19,780

     

    3.Advisory Vote to Approve Executive Compensation. Shareholders approved, on an advisory basis, the compensation of our named executive officers, as disclosed in the Proxy Statement, by the votes set forth in the table below.

     

    Voted For   Voted Against   Abstain   Broker Non-Votes
    95,176,785   993,998    41,210    4,619,784 

     

    Approval of Charter Amendments to:

     

    4a.Provide that the By-laws may be amended by majority vote. The Charter Amendment to provide that the By-laws may be amended by majority vote was approved by the shareholders by the votes set forth in the table below.

     

    Voted For   Voted Against   Abstain   Broker Non-Votes
    95,960,964    230,595    20,434    4,619,784 

     

    4b.Allow the Charter to be amended in the future by majority vote. The Charter Amendment to allow the Charter to be amended in the future by majority vote was approved by the shareholders by the votes set forth in the table below.

     

    Voted For   Voted Against   Abstain   Broker Non-Votes
    95,952,318    238,075    21,600    4,619,784 

     

    4c.Allow the filling of open Board seats at statutorily required special meetings under the standard in the By-laws. The Charter Amendment to allow the filling of open Board seats at statutorily required special meetings under the standard in the By-laws was approved by the shareholders by the votes set forth in the table below.

     

    Voted For   Voted Against   Abstain   Broker Non-Votes
    95,980,376    211,072    20,545    4,619,784 

     

    4d.Allow directors to be removed by majority vote. The Charter Amendment to allow directors to be removed by majority vote was approved by the shareholders by the votes set forth in the table below.

     

    Voted For   Voted Against   Abstain   Broker Non-Votes
    96,033,389    159,424    19,180    4,619,784 

     

    5.Advisory Vote on Shareholder Proposal Requesting Simple Majority Vote Charter and By-laws Amendments, if Properly Presented. Shareholders approved, on an advisory basis, the shareholder proposal requesting simple majority vote Charter and By-laws amendments by the votes set forth in the table below.

     

    Voted For   Voted Against   Abstain   Broker Non-Votes
    61,973,184    34,205,495    33,314    4,620,221 

     

    3

     

     

    Item 9.01Financial Statements and Exhibits.

     

    (d)            Exhibits.

     

    Exhibit

    Number

      Description
         
    3.1   Certificate of Amendment of Second Amended and Restated Certificate of Incorporation of Celanese Corporation, effective May 15, 2025.
         
    3.2   Certificate of Elimination of 4.25% Convertible Perpetual Preferred Stock of Celanese Corporation, effective May 15, 2025.
         
    3.3   Restated Certificate of Incorporation of Celanese Corporation, effective May 15, 2025.
         
    3.4   Amended and Restated By-laws of Celanese Corporation, effective May 15, 2025.
         
    104   Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document contained in Exhibit 101)

     

    4

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

     

    CELANESE CORPORATION

       
      By: /s/ ASHLEY B. DUFFIE
      Name:  Ashley B. Duffie
      Title: Senior Vice President, General Counsel and Corporate Secretary 
         
      Date: May 15, 2025

     

    5

     

    Get the next $CE alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CE

    DatePrice TargetRatingAnalyst
    5/20/2025$55.00Underperform → Market Perform
    BMO Capital Markets
    3/21/2025$76.00Sector Weight → Overweight
    KeyBanc Capital Markets
    3/17/2025$70.00Neutral → Overweight
    Alembic Global Advisors
    3/6/2025$66.00Sell → Hold
    Vertical Research
    2/20/2025$84.00 → $56.00Outperform → Sector Perform
    RBC Capital Mkts
    1/14/2025$95.00 → $88.00Underperform → Buy
    BofA Securities
    11/11/2024$161.00 → $97.00Buy → Neutral
    UBS
    11/11/2024$138.00 → $76.00Market Perform → Underperform
    BMO Capital Markets
    More analyst ratings

    $CE
    SEC Filings

    See more
    • Celanese Corporation filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

      8-K - Celanese Corp (0001306830) (Filer)

      5/15/25 9:00:48 PM ET
      $CE
      Major Chemicals
      Industrials
    • Amendment: SEC Form SCHEDULE 13G/A filed by Celanese Corporation

      SCHEDULE 13G/A - Celanese Corp (0001306830) (Subject)

      5/14/25 4:22:41 PM ET
      $CE
      Major Chemicals
      Industrials
    • SEC Form 10-Q filed by Celanese Corporation

      10-Q - Celanese Corp (0001306830) (Filer)

      5/6/25 4:12:38 PM ET
      $CE
      Major Chemicals
      Industrials

    $CE
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Celanese Announces Engineered Materials Price Increases

      Celanese Corporation (NYSE:CE), a global specialty materials and chemical company, will increase prices for a range of products and wishes to provide our customers context for our decision and appropriate notice for planning purposes. Given the dynamic conditions of global trade, Celanese is uniquely positioned to actively manage our global and regional operations to support our valued customers around the world with enhanced supply continuity. These price increases are associated with, among others, heightened costs of product movement and inventory repositioning, plant operational expenses, changing trade regulations, and raw materials. The price increases will be effective on June 1, 202

      5/5/25 5:14:00 PM ET
      $CE
      Major Chemicals
      Industrials
    • Celanese Corporation Reports First Quarter Earnings

      Celanese Corporation (NYSE:CE), a global chemical and specialty materials company, today reported first quarter 2025 U.S. GAAP diluted loss per share of $0.15 and adjusted earnings per share of $0.57. The Company generated net sales of $2.4 billion in the first quarter, a 1 percent increase from the previous quarter driven by a 2 percent increase in volume, with a small offset in currency. Most end-markets developed as anticipated, with persistent global demand sluggishness, especially in key segments like automotive, paints, coatings, and construction. Celanese continued to drive self-help measures in support of the three strategic priorities of increasing cash to deleverage the balance sh

      5/5/25 4:55:00 PM ET
      $CE
      Major Chemicals
      Industrials
    • Celanese Announces Intent to Divest Micromax® Business to Advance Deleveraging and Cash Generation Efforts

      Celanese Corporation (NYSE:CE), a global specialty materials and chemical company, today announced its intent to divest its Micromax® portfolio of products. The Company's Board and management are confident in the significant value created by a divestment while advancing Celanese's strategic priority of cash generation and deleveraging. "Our primary focus continues to be aggressively and prudently deleveraging our balance sheet, and this strategy includes regularly reviewing our assets," said Scott Richardson, Celanese's president and chief executive officer. "As I've shared previously, we are actively exploring several opportunities for cash generation, including the divestiture of the Mic

      5/5/25 4:00:00 PM ET
      $CE
      Major Chemicals
      Industrials

    $CE
    Leadership Updates

    Live Leadership Updates

    See more
    • DoorDash, TKO Group Holdings, Williams-Sonoma and Expand Energy Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600

      NEW YORK, March 7, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, March 24, to coincide with the quarterly rebalance. The changes ensure each index is more representative of its market capitalization range. All companies being added to the S&P 100 are more representative of the mega-cap market space. All companies being added to the S&P 500 are more representative of the large-cap market space, all companies being added to the S&P MidCap 400 are more representative of the mid-cap market space, and all companies being added to the S&P

      3/7/25 6:19:00 PM ET
      $ALK
      $AMBC
      $ATI
      $BBWI
      Air Freight/Delivery Services
      Consumer Discretionary
      Property-Casualty Insurers
      Finance
    • Scott Sutton Elected to Celanese Board of Directors

      Board Establishes Finance and Business Review Committee to Assist with Oversight of the Company's Financial Position and Business Improvement Initiatives Celanese Corporation (NYSE:CE), a global chemical and specialty materials company, today announced the election of Scott Sutton to the company's Board of Directors. Mr. Sutton, 60, will join the Celanese Board effective March 1, 2025, and stand for re-election at the 2025 Annual Meeting of Shareholders. In addition, the Board has established a Finance and Business Review Committee, to assist with oversight of the company's financial position and strategy, including its efforts to further reduce costs, prioritize cash flow, accelerate del

      2/14/25 9:15:00 AM ET
      $CE
      Major Chemicals
      Industrials
    • Celanese Announces New Leadership Appointment to Drive Growth and Profitability

      Todd Elliott Rejoins Celanese to Lead Engineered Materials Celanese Corporation (NYSE:CE), a global chemical and specialty materials company, today announced a new addition to its Executive Leadership Team (ELT). Todd Elliott, a proven executive who retired from Celanese in 2020 as Senior Vice President (SVP) and head of the Acetyls business, will return to the Company as SVP to lead the Engineered Materials (EM) business, effective February 3, 2025. Elliott will succeed Tom Kelly, who is stepping down as SVP, Engineered Materials and will serve in a transition role through March 10, 2025. Elliott had a diverse and successful career with Celanese, progressing through multiple leadersh

      1/16/25 4:15:00 PM ET
      $CE
      Major Chemicals
      Industrials

    $CE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Celanese upgraded by BMO Capital Markets with a new price target

      BMO Capital Markets upgraded Celanese from Underperform to Market Perform and set a new price target of $55.00

      5/20/25 8:01:00 AM ET
      $CE
      Major Chemicals
      Industrials
    • Celanese upgraded by KeyBanc Capital Markets with a new price target

      KeyBanc Capital Markets upgraded Celanese from Sector Weight to Overweight and set a new price target of $76.00

      3/21/25 8:01:25 AM ET
      $CE
      Major Chemicals
      Industrials
    • Celanese upgraded by Alembic Global Advisors with a new price target

      Alembic Global Advisors upgraded Celanese from Neutral to Overweight and set a new price target of $70.00

      3/17/25 7:28:00 AM ET
      $CE
      Major Chemicals
      Industrials

    $CE
    Financials

    Live finance-specific insights

    See more
    • Celanese Corporation Reports First Quarter Earnings

      Celanese Corporation (NYSE:CE), a global chemical and specialty materials company, today reported first quarter 2025 U.S. GAAP diluted loss per share of $0.15 and adjusted earnings per share of $0.57. The Company generated net sales of $2.4 billion in the first quarter, a 1 percent increase from the previous quarter driven by a 2 percent increase in volume, with a small offset in currency. Most end-markets developed as anticipated, with persistent global demand sluggishness, especially in key segments like automotive, paints, coatings, and construction. Celanese continued to drive self-help measures in support of the three strategic priorities of increasing cash to deleverage the balance sh

      5/5/25 4:55:00 PM ET
      $CE
      Major Chemicals
      Industrials
    • Celanese Corporation Declares Quarterly Dividend of $0.03 Per Share

      Celanese Corporation (NYSE:CE), a global chemical and specialty materials company, today declared a quarterly cash dividend of $0.03 per share on its common stock, payable May 12, 2025. The dividend is payable to stockholders of record as of April 28, 2025. About Celanese Celanese is a global leader in chemistry, producing specialty material solutions used across most major industries and consumer applications. Our businesses use our chemistry, technology and commercial expertise to create value for our customers, employees and shareholders. We support sustainability by responsibly managing the materials we create and growing our portfolio of sustainable products to meet customer and soc

      4/16/25 4:15:00 PM ET
      $CE
      Major Chemicals
      Industrials
    • Celanese to Hold First Quarter Earnings Conference Call on May 6, 2025

      Celanese Corporation (NYSE:CE), a global chemical and specialty materials company, today announced that it will host a conference call to discuss its first quarter 2025 results on Tuesday, May 6, 2025, beginning at 9:00 a.m. ET. The conference call will be available by webcast at https://investors.celanese.com or by phone: Dial-in Number: 1-877-407-0989 International Dial-In Number: 1-201-389-0921 Alternatively, to enter the call immediately without waiting for operator assistance, attendees may pre-register for the call by clicking the link below. Registrant Link: http://services.incommconferencing.com/DiamondPassRegistration/register?confirmationNumber=13752935&linkSecurityString=1de9

      4/1/25 4:00:00 PM ET
      $CE
      Major Chemicals
      Industrials

    $CE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Moorthy Ganesh bought $53,290 worth of shares (1,000 units at $53.29) (SEC Form 4)

      4 - Celanese Corp (0001306830) (Issuer)

      3/13/25 4:47:56 PM ET
      $CE
      Major Chemicals
      Industrials
    • Director Sutton Scott Mcdougald bought $407,119 worth of shares (7,450 units at $54.65), increasing direct ownership by 99% to 15,000 units (SEC Form 4)

      4 - Celanese Corp (0001306830) (Issuer)

      3/10/25 5:17:56 PM ET
      $CE
      Major Chemicals
      Industrials
    • SVP - Acetyls Murray Mark Christopher bought $128,110 worth of shares (2,353 units at $54.45), increasing direct ownership by 20% to 13,989 units (SEC Form 4)

      4 - Celanese Corp (0001306830) (Issuer)

      3/10/25 5:14:49 PM ET
      $CE
      Major Chemicals
      Industrials

    $CE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Koenig Michael covered exercise/tax liability with 335 shares, decreasing direct ownership by 5% to 6,358 units (SEC Form 4)

      4 - Celanese Corp (0001306830) (Issuer)

      5/19/25 4:20:29 PM ET
      $CE
      Major Chemicals
      Industrials
    • Director Rucker Kim K.W. returned 1,114 shares to the company, decreasing direct ownership by 25% to 3,432 units (SEC Form 4)

      4 - Celanese Corp (0001306830) (Issuer)

      5/19/25 8:01:17 AM ET
      $CE
      Major Chemicals
      Industrials
    • Director Kissire Deborah J. returned 1,114 shares to the company, decreasing direct ownership by 20% to 4,476 units (SEC Form 4)

      4 - Celanese Corp (0001306830) (Issuer)

      5/19/25 7:58:31 AM ET
      $CE
      Major Chemicals
      Industrials

    $CE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Celanese Corporation

      SC 13G/A - Celanese Corp (0001306830) (Subject)

      12/6/24 12:11:25 PM ET
      $CE
      Major Chemicals
      Industrials
    • Amendment: SEC Form SC 13G/A filed by Celanese Corporation

      SC 13G/A - Celanese Corp (0001306830) (Subject)

      12/5/24 2:20:23 PM ET
      $CE
      Major Chemicals
      Industrials
    • Amendment: SEC Form SC 13G/A filed by Celanese Corporation

      SC 13G/A - Celanese Corp (0001306830) (Subject)

      11/13/24 12:52:42 PM ET
      $CE
      Major Chemicals
      Industrials